doi: 10.1172/JCI146353 Summary Keywords GIP, GLP-1, tirzepatide, basal insulin, type 2 diabetes, obesity, body weight, hypoglycemia Citation Lisco G, De Tullio A, Disoteo O, De Geronimo V, Piazzolla G, De Pergola G, Giagulli VA, Jirillo E, Guastamacchia E, Sabb C and Triggiani V (2022) Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis
It will be interesting to see which company, Novo Nordisk or Eli Lilly, will reach the trillion-dollar mark first
However, since we tailor your B12 shots to suit your needs, we highly recommend reviewing your health and health goals with us to create a customized treatment plan
Thats when unit mismatches and rounding can create big relative errors
Studies were uploaded in Covidence (Melbourne, VIC, Australia) for deduplication and data extraction
If you are considering stopping GLP-1 therapy, discuss a structured monitoring plan with your GP or specialist, including regular checks of HbA1c, weight, blood pressure and lipids
.jpg)
